CTI Life Sciences Fund
Venture capital firm · Founded 2006 · Montreal, Quebec, Canada · Toronto ↗
CTI Life Sciences Fund makes venture capital investments in high-quality emerging life science companies at the pre-clinical and clinical development stages. The Montreal-based firm, founded in 2006, invests primarily in Canada, with a portion of its investments also in the United States and Europe, across three funds.
Tier reflects published scale and track-record signals. It is not a rating of the firm as a partner.
This profile is unclaimed. Built from public sources. If you're a partner or employee at CTI Life Sciences Fund, you can claim it.
Claim this profileHow claiming worksKey numbers
Assets under management
LAST CHECKED NOV 2026
Latest fund
LAST CHECKED NOV 2026
Funds
3
Check size
LAST CHECKED NOV 2026
Stages
GrowthSeedSeries ASeries B
Sectors
life sciencesbiotechnologytherapeuticshealthcare
FIGURES ARE AS PUBLISHED IN THE CATALOG RECORD 1 · PER-FIGURE AS-OF DATES ARE NOT YET IN THE CATALOG
Track record
Hits
- Enobia Pharma
Acquired by Alexion Pharmaceuticals (US$1.1B, 2012) — CTI's early exits include Enobia Pharma, acquired by Alexion Pharmaceuticals in a US $1.1-billion deal that closed in February 2012.
Source: drug-dev.com
Misses
Track record
Partners 5
- Jean-Francois Leprince
Managing Partner
Board seats
No public record - Ken Pastor
Partner
Board seats
No public record - Shermaine Tilley
Partner
Board seats
No public record - Laurence Rulleau
Partner
Board seats
No public record - Youssef Bennani
Managing Partner
Board seats
No public record
Reputation 2
No reputation score — basis not established for this firm.
- Top VCs in Montreal: CTI Life Sciences Fund - IncubatorList
incubatorlist.com
- CTI Life Sciences Fund investor profile - PitchBook
pitchbook.com
Contact
Published sources only
Published contact
- Website
- www.ctisciences.com
Published sources only
GlassVC lists only contact information the firm or its sources have published. We do not list personal emails, direct lines, or private addresses.
SOURCE: FIRM WEBSITE, AS PUBLISHED 2
What founders say
Founder-submitted · Verified identity and relationship
No founder reviews yet
Be the first founder to share your experience with CTI Life Sciences Fund. Reviews come from founders whose identity and relationship have been verified.
Write the first reviewMethodology
Tier basis — AUM not publicly disclosed — grouped with emerging firms by default (AUM-band grouping — full tier basis pending in the catalog). Tier reflects published scale and track-record signals. It is not a rating of the firm as a partner.
Figures are shown as published; conflicting figures are never averaged. Review dimension scores appear only once three founders have reviewed this firm; profiles below that threshold do not appear in rated lists.
The catalog does not yet carry per-figure citations or as-of dates: every figure on this page traces to the catalog record listed below, and that limit is stated rather than papered over. Corrections with a source: Suggest a correction.
Source record 2
- [1]
DATABASE · GlassVC catalog — Catalog record for CTI Life Sciences Fund — provenance: GlassVC catalog census, November 2026
↩ cites: AUM · Check size · Founded · HQ · Stages · Sectors · Funds · Track record · Reputation
- [2]
FIRM SITE · CTI Life Sciences Fund — Firm website, as published by the firm
PROFILE BUILT FROM PUBLIC SOURCES · 2 CATALOG SOURCES · LAST CHECKED NOV 2026
